The Latest News and Select Stories About Intrance Medical Systems

January 4, 2022

Intrance Medical Systems Completes $17 Million Series A Financing and Appoints Ed Schutter to Board of Directors

November 2, 2021

Leading US-Swedish entrepreneur Rutger Arnhult invests in Intrance Medical Inc’s advanced stage Parkinson’s disease treatment system

September 20, 2021

Intrance Medical Systems Raises $8 Million to Support Development of Its Innovative Therapy for Advanced Parkinson’s Disease

August 17, 2021

Intrance Medical Systems Names Krai Chatamra, Ph.D., Vice President of Clinical Development

May 13, 2021

Intrance Medical Systems Establishes U.S. Operations and Names Patrick Shea Chief Executive Officer

October 2, 2020

STADA expands specialty footprint through acquisition of innovative therapy for treating advanced Parkinson’s disease

September 17, 2020

Lobsor Pharmaceuticals receives approval for Lecigon in Germany, the Netherlands, Belgium, Austria, Slovenia and Romania

October 30, 2019

Japanese patent granted for Lobsor Pharmaceuticals’ new therapeutic system Lecigon®

October 1, 2019

Lobsor receives approval for Lecigon® in Denmark, Finland and Norway

November 2, 2015

Primary endpoint achieved in pivotal EU study